Thryv Therapeutics
Thryv Therapeutics Inc. (previously LQT Therapeutics Inc.) is a privately owned company based in Montreal, Quebec, Canada. Thryv Therapeutics is pioneering a precision medicine approach to treat Congenital Long QT Syndromes (LQTS), atrial fibrillation, and resistant cancers with potent and selective
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-03 | 3.894 |
| 2025-04 | 3.848 |
| 2025-05 | 1.728 |
| Source | Traffic Share |
|---|---|
| search | 46.21% |
| direct | 23.99% |
| referrals | 18.75% |
| social | 9.88% |
| paid referrals | 0.99% |
| 0.07% |
| Region | Percentage |
|---|---|
| United States | 80.46% |
| India | 19.54% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| long qt syndrome graphics | 17 | 170 | $0.00 |
| downtown companies | 5 | 50 | $0.00 |
| thryv therapeutics | 5 | 50 | $0.00 |
| thryv | 1,845 | 18,450 | $5.36 |
| thryv careers | 81 | 810 | $0.00 |